At a meeting of the European Commission today representatives from all EU Member States met in Brussels to consider the status of medical oncology as a recognized specialty under EU law.
“Such recognition is an essential step in providing optimal treatment to the millions of Europeans who have cancer or who develop cancer every year,” says Dr. Jose Baselga, ESMO President-Elect. It would enable the free movement of medical oncologists within EU Member States, with their professional qualifications being automatically recognized.
“A determining factor for optimal cancer treatment and research is the level of training, knowledge and skills of oncology professionals,” says Dr. Baselga.
Medical oncologists are doctors who specialize in taking care of cancer patients. They have training in internal medicine, and subsequent specialization in the comprehensive management of patients with malignancies.
Medical oncologists are trained in the scientific basis of cancer treatment, prevention, screening, and diagnosis. Hospitals in every European country, and around the world, employ medical oncologists to help treat their patients.
“Medical oncology is recognized as a specialty in most of the EU Member States, the United States and many other countries around the world,” says Dr. Adamos Adamou, co-chair of the European Members of Parliament Against Cancer (MAC). “We believe it is time the EU joined them.”
Working in multidisciplinary teams with surgeons and radiation oncologists, medical oncologists are responsible for the systemic treatment of cancer patients with chemotherapy, hormonal therapy, immune and targeted therapies, as well as supportive care. Medical oncologists also engage in clinical cancer research in the form of clinical trials.
Currently, however, the specialty of medical oncology is not formally recognized by the European Union. Discussions within the EU have been ongoing for some time in a continuing and concerted effort on the part of medical professionals from across the continent to achieve that recognition.
“We urge patients and politicians to voice their support for the recognition of medical oncology as a specialty, and to agree on minimum training periods,” says Pascale Blaes, Director of the ESMO Brussels office.
“Oncologists and cancer patients across the EU will be watching the outcome closely, because of the growing urgency to keep cancer as a high priority on the EU healthcare agenda,” Pascale Blaes says.
Improving memory with magnets
28.03.2017 | McGill University
Graphene-based neural probes probe brain activity in high resolution
28.03.2017 | Graphene Flagship
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
28.03.2017 | Life Sciences
28.03.2017 | Information Technology
28.03.2017 | Physics and Astronomy